Published in Forbes, May 13, 2025
Dr. Steve Brozak, President of WBB Securities, has authored a new opinion piece in Forbes exploring President Donald Trump’s evolving role in the fight to lower drug prices in America.
In the article, Dr. Brozak examines:
- Trump’s past and current positions on drug pricing reform
- The potential political and market impact of drug price equalization
“The reality is that drug pricing affects every American, and whoever speaks to that challenge in a credible way will command attention,” Brozak writes.
📖 Read the full article on Forbes:
👉 President Donald Trump – Will He Become the Drug Price Equalizer?
This article was written by Dr. Steve Brozak and originally published by Forbes on May 13, 2025.
